Dapagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, Acutely Reduces Energy Expenditure in BAT via Neural Signals in Mice
Yumiko Chiba, Tetsuya Yamada, Sohei Tsukita, Kei Takahashi, Yuichiro Munakata, Yuta Shirai, Shinjiro Kodama, Yoichiro Asai, Takashi Sugisawa, Kenji Uno, Shojiro Sawada, Junta Imai, Kazuhiro Nakamura, Hideki Katagiri, Yumiko Chiba, Tetsuya Yamada, Sohei Tsukita, Kei Takahashi, Yuichiro Munakata, Yuta Shirai, Shinjiro Kodama, Yoichiro Asai, Takashi Sugisawa, Kenji Uno, Shojiro Sawada, Junta Imai, Kazuhiro Nakamura, Hideki Katagiri
Abstract
Selective sodium glucose cotransporter-2 inhibitor (SGLT2i) treatment promotes urinary glucose excretion, thereby reducing blood glucose as well as body weight. However, only limited body weight reductions are achieved with SGLT2i treatment. Hyperphagia is reportedly one of the causes of this limited weight loss. However, the effects of SGLT2i treatment on systemic energy expenditure have not been fully elucidated. Herein, we investigated the acute effects of dapagliflozin, a SGLT2i, on systemic energy expenditure in mice. Eighteen hours after dapagliflozin treatment oxygen consumption and brown adipose tissue (BAT) expression of ucp1, a thermogenesis-related gene, were significantly decreased as compared to those after vehicle treatment. In addition, dapagliflozin significantly suppressed norepinephrine (NE) turnover in BAT and c-fos expression in the rostral raphe pallidus nucleus (rRPa) which contains the sympathetic premotor neurons responsible for thermogenesis. These findings indicate that the dapagliflozin-mediated acute decrease in energy expenditure involves a reduction in BAT thermogenesis via decreased sympathetic nerve activity from the rRPa. Furthermore, common hepatic branch vagotomy abolished the reductions in ucp1 expression and NE contents in BAT and c-fos expression in the rRPa. In addition, alterations in hepatic carbohydrate metabolism, such as decreases in glycogen contents and upregulation of phosphoenolpyruvate carboxykinase, manifested prior to the suppression of BAT thermogenesis, e.g. 6 hours after dapagliflozin treatment. Collectively, these results suggest that SGLT2i treatment acutely suppresses energy expenditure in BAT via regulation of an inter-organ neural network consisting of the common hepatic vagal branch and sympathetic nerves.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Vallon V (2015) The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus. Annu Rev Med 66: 255–270. 10.1146/annurev-med-051013-110046
- Ferrannini E, Solini A (2012) SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects. Nat Rev Endocrinol 8: 495–502. 10.1038/nrendo.2011.243
- Bailey CJ (2011) Renal glucose reabsorption inhibitors to treat diabetes. Trends Pharmacol Sci 32: 63–71. 10.1016/j.tips.2010.11.011
- List JF, Woo V, Morales E, Tang W, Fiedorek FT (2009) Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes. Diabetes Care 32: 650–657. 10.2337/dc08-1863
- Vickers SP, Cheetham SC, Headland KR, Dickinson K, Grempler R, et al. (2014) Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet. Diabetes Metab Syndr Obes 7: 265–275. 10.2147/DMSO.S58786
- Devenny JJ, Godonis HE, Harvey SJ, Rooney S, Cullen MJ, et al. (2012) Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats. Obesity (Silver Spring) 20: 1645–1652.
- Nagata T, Fukuzawa T, Takeda M, Fukazawa M, Mori T, et al. (2013) Tofogliflozin, a novel sodium-glucose co-transporter 2 inhibitor, improves renal and pancreatic function in db/db mice. Br J Pharmacol 170: 519–531. 10.1111/bph.12269
- Ferrannini G, Hach T, Crowe S, Sanghvi A, Hall KD, et al. (2015) Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition. Diabetes Care 38: 1730–1735. 10.2337/dc15-0355
- Takahashi K, Yamada T, Tsukita S, Kaneko K, Shirai Y, et al. (2013) Chronic mild stress alters circadian expressions of molecular clock genes in the liver. Am J Physiol Endocrinol Metab 304: E301–309. 10.1152/ajpendo.00388.2012
- Tsukita S, Yamada T, Uno K, Takahashi K, Kaneko K, et al. (2012) Hepatic glucokinase modulates obesity predisposition by regulating BAT thermogenesis via neural signals. Cell Metab 16: 825–832. 10.1016/j.cmet.2012.11.006
- Uno K, Katagiri H, Yamada T, Ishigaki Y, Ogihara T, et al. (2006) Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 312: 1656–1659.
- Desautels M, Dulos RA (1988) Effects of repeated cycles of fasting-refeeding on brown adipose tissue composition in mice. Am J Physiol 255: E120–128.
- Morrison SF, Nakamura K, Madden CJ (2008) Central control of thermogenesis in mammals. Exp Physiol 93: 773–797. 10.1113/expphysiol.2007.041848
- Young JB, Saville E, Rothwell NJ, Stock MJ, Landsberg L (1982) Effect of diet and cold exposure on norepinephrine turnover in brown adipose tissue of the rat. J Clin Invest 69: 1061–1071.
- Nakamura K, Matsumura K, Kaneko T, Kobayashi S, Katoh H, et al. (2002) The rostral raphe pallidus nucleus mediates pyrogenic transmission from the preoptic area. J Neurosci 22: 4600–4610.
- Izumida Y, Yahagi N, Takeuchi Y, Nishi M, Shikama A, et al. (2013) Glycogen shortage during fasting triggers liver-brain-adipose neurocircuitry to facilitate fat utilization. Nat Commun 4: 2316 10.1038/ncomms3316
- Uno K, Yamada T, Ishigaki Y, Imai J, Hasegawa Y, et al. (2015) A hepatic amino acid/mTOR/S6K-dependent signalling pathway modulates systemic lipid metabolism via neuronal signals. Nat Commun 6: 7940 10.1038/ncomms8940
- Yokono M, Takasu T, Hayashizaki Y, Mitsuoka K, Kihara R, et al. (2014) SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats. Eur J Pharmacol 727: 66–74. 10.1016/j.ejphar.2014.01.040
- van Marken Lichtenbelt WD, Schrauwen P (2011) Implications of nonshivering thermogenesis for energy balance regulation in humans. Am J Physiol Regul Integr Comp Physiol 301: R285–296. 10.1152/ajpregu.00652.2010
- Shibata H, Bukowiecki LJ (1987) Regulatory alterations of daily energy expenditure induced by fasting or overfeeding in unrestrained rats. J Appl Physiol (1985) 63: 465–470.
- Berthoud HR (2004) Anatomy and function of sensory hepatic nerves. Anat Rec A Discov Mol Cell Evol Biol 280: 827–835.
- Tahara A, Kurosaki E, Yokono M, Yamajuku D, Kihara R, et al. (2012) Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo. Naunyn Schmiedebergs Arch Pharmacol 385: 423–436. 10.1007/s00210-011-0713-z
- Chen LH, Leung PS (2013) Inhibition of the sodium glucose co-transporter-2: its beneficial action and potential combination therapy for type 2 diabetes mellitus. Diabetes Obes Metab 15: 392–402. 10.1111/dom.12064
- Niijima A (1988) The effect of endogenous sugar acids on the afferent discharge rate of the hepatic branch of the vagus nerve in the rat. Physiol Behav 44: 661–664.
Source: PubMed